Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating cash flows:
Net income before non-controlling interests	$ 1,086	$ 998
Adjustments to reconcile net income used for operations:
Depreciation and amortization of fixed assets and capitalized software	89	97
Amortization of intangible assets	91	100
Non cash lease expense	77	79
Adjustments and payments related to contingent consideration assets and liabilities	10	(1)
Deconsolidation of Russian businesses	39	0
Net gain on investments	(26)	(11)
Net (gain) loss on disposition of assets	(1)	3
Share-based compensation expense	105	78
Changes in assets and liabilities:
Net receivables	(429)	(404)
Other assets	(117)	(116)
Accrued compensation and employee benefits	(1,528)	(1,167)
Provision for taxes, net of payments and refunds	144	198
Contributions to pension and other benefit plans in excess of current year credit	(125)	(102)
Other liabilities	(33)	(78)
Operating lease liabilities	(84)	(82)
Net cash used for operations	(702)	(408)
Financing cash flows:
Purchase of treasury shares	(500)	(112)
Net proceeds from issuance of commercial paper	825	0
Repayments of debt	(4)	(4)
Shares withheld for taxes on vested units – treasury shares	(134)	(93)
Issuance of common stock from treasury shares	34	35
Payments of deferred and contingent consideration for acquisitions	(16)	(32)
Receipts of contingent consideration for dispositions	3	0
Distributions of non-controlling interests	(7)	(8)
Dividends paid	(272)	(237)
Change in fiduciary liabilities	926	190
Net cash provided by (used for) financing activities	855	(261)
Investing cash flows:
Capital expenditures	(122)	(69)
Net (purchases) sale of long term investments	(8)	4
Dispositions	(4)	0
Acquisitions	(24)	0
Other, net	(1)	(2)
Net cash used for investing activities	(159)	(67)
Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity	(136)	(36)
Decrease in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity	(142)	(772)
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period	11,375	10,674
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period	11,233	9,902
Cash and cash equivalents	772	1,120
Cash and cash equivalents held in a fiduciary capacity	10,461	8,782
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity	$ 11,233	$ 9,902